Search clinical trials for: Dutasteride (GI198745)

Total 127 results

GlaxoSmithKline

Completed

Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Benign Prostatic Hyperplasia
GlaxoSmithKline

Completed

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Prostatic Hyperplasia

Japan
GlaxoSmithKline

Completed

Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers

Alopecia

Australia
GlaxoSmithKline

Completed

A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (ARI115707)

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State

Urologic Diseases

United Kingdom
GlaxoSmithKline

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (ARI114694)

Prostatic Hyperplasia

Australia
EMS

Not yet recruiting

Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia (AUSTRÁLIA)

Erectile Dysfunction | Prostatic Hyperplasia, Benign

Brazil
Bio-innova Co., Ltd

Not yet recruiting

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

Healthy Subjects
Tanta University

Not yet recruiting

Beneficial Effect of Silymarin in Ulcerative Colitis

Ulcerative Colitis
Clinica Dermatologica Arbache ltda

Recruiting

MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine) (MMP)

Androgenic Alopecia

Brazil
Turku University Hospital

Recruiting

Prostate Medication, Metabolism and Gut Microbiota (PROMED)

Prostatic Hyperplasia | Prostate Cancer

Finland
Wuerzburg University Hospital
University of Wuerzburg

Recruiting

Impact of Pycnogenol® on Gingival Inflammation (PINEGIN)

Periodontitis

Germany
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Phase II Dutasteride in Combination With CAB vs CAB in SDC (DUCT)

Salivary Duct Carcinoma

Netherlands
Pellficure Pharmaceuticals, Inc

Terminated

Study of PCUR-101 in Combination With ADT in Patients With mCRPC

Prostate Cancer

United States, Australia
En Chu Kong Hospital

Completed

The Changes of Urine Growth Factors Level

Benign Prostatic Hyperplasia

Taiwan
CHU de Quebec-Universite Laval
Prostate Cancer Canada

Active, not recruiting

Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression

Prostatic Neoplasms | Low Grade Prostate Cancer

Canada
University of Rochester

Completed

Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.

Prostate Cancer

United States
Elpen Pharmaceutical Co. Inc.

Completed

Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II) (PROSPERITY)

Benign Prostatic Hyperplasia

Greece
Dongkook Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Korea, Republic of
NorthShore University HealthSystem
Northwestern University; University of Chicago

Completed

Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer

Prostate Cancer

United States
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Active, not recruiting

Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy

Alcohol Use Disorder

United States
CHU de Quebec-Universite Laval
GlaxoSmithKline

Completed

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

Lower Urinary Tract Symptoms | Erectile Dysfunction | Prostate Cancer

Canada
Fundacion para la Investigacion Biomedica del Hospital...

Active, not recruiting

Exploratory Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.

Male Androgenetic Alopecia

Spain
University of Chicago

Active, not recruiting

Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer

Prostate Cancer

United States
Masonic Cancer Center, University of Minnesota

Withdrawn

Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)

Prostate Cancer
Dongkook Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Characteristics of DKF-313

Healthy | Benign Prostate Hyperplasia

Korea, Republic of
Ain Shams University

Completed

Role of Dutasteride in Treatment of Chronic Prostatitis

Dutasteride | Category IIIB Chronic Prostatitis

Egypt
Corpometria Institute

Completed

EAT-DUTA AndroCoV Trial

Covid19

Brazil
Addpharma Inc.

Completed

To Evaluate the Pharmacokinetics and Safety of AD-208

Androgenetic Alopecia

Korea, Republic of
University of Illinois at Chicago
National Cancer Institute (NCI)

Completed

Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

Prostate Cancer

United States
University of Illinois at Chicago
GlaxoSmithKline

Completed

Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue

Benign Prostate Tissue

United States
Unita Complessa di Ostetricia e Ginecologia

Completed

Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen (DUTMUSCLE-20)

Hypogonadism | Transgenderism
University of Washington

Withdrawn

ITT-5 Mechanisms of Spermatogenesis in Man (ITT-5)

Gonadotropin Deficiency

United States
National Institute of Mental Health (NIMH)

Completed

Dutasteride to Treat Women With Menstrually Related Mood Disorders

Depression | Healthy | Premenstrual Syndrome | PMS

United States
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Dutasteride Treatment for the Reduction of Heavy Drinking in Men

Alcohol Dependence | Alcoholism | Alcohol Abuse

United States
GlaxoSmithKline

Completed

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Korea, Republic of, China, Japan, Taiwan
Siami, Paul F., M.D.
GlaxoSmithKline

Completed

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer

Prostate Cancer

Canada, United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

Alopecia

Korea, Republic of, Taiwan, Singapore, Hong Kong, Chile
GlaxoSmithKline

Completed

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State

Urologic Diseases

United Kingdom
Dana-Farber Cancer Institute
Massachusetts General Hospital; GlaxoSmithKline; Beth Israel Deaconess Medical... and other collaborators

Terminated

Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer (KHLAD)

Prostate Cancer

United States
GlaxoSmithKline

Terminated

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia (FDC114785)

Prostatic Hyperplasia

Vietnam
GlaxoSmithKline

Completed

Prospective Sexual Function Study for BPH Subjects

Prostatic Hyperplasia

Germany, Australia, Netherlands, Spain, Hungary, France, Greece
GlaxoSmithKline

Completed

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement (CONDUCT)

Prostatic Hyperplasia

Italy, Spain, United Kingdom, Netherlands, Greece, Romania, France, Germany
GlaxoSmithKline

Completed

A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia

Alopecia
GlaxoSmithKline

Completed

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

Androgenetic Alopecia

Japan, Argentina, Peru, Philippines, Taiwan, Mexico, Chile, Russian Federation, Thailand
University of Washington
GlaxoSmithKline; AstraZeneca

Completed

Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer (TAPS)

Cancer | Prostate Neoplasms

United States
GlaxoSmithKline

Completed

A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia

Alopecia

Japan

3

Subscribe